Marshall Wace
XBIT icon

Marshall Wace’s XBiotech XBIT Stock Holding History

Marshall Wace’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,573
Closed -$54.3K – 3010
2024
Q2 		$54.3K Sell
10,573
-44,106
-81% -$340K ﹤0.01% 2442
2024
Q1 		$445K Buy
+54,679
New +$313K ﹤0.01% 1979
2022
Q1 		– Sell
-24,176
Closed -$269K – 4108
2021
Q4 		$269K Buy
+24,176
New +$315K ﹤0.01% 3066
2020
Q2 		– Sell
-22,128
Closed -$235K – 1999
2020
Q1 		$235K Buy
+22,128
New +$360K ﹤0.01% 1154
2019
Q2 		– Sell
-61,914
Closed -$682K – 1908
2019
Q1 		$682K Buy
+61,914
New +$502K 0.01% 1044

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Marshall Wace's XBIT Position: Q3 2024 in Review

Marshall Wace sold out of XBiotech (XBIT) in Q3 2024, closing a stake of 10,573 shares — an estimated $54.3K sold.

Marshall Wace first reported a position in XBIT in Q1 2019 and held it in 5 quarters. The position peaked at $682K in Q1 2019. 50 funds tracked by Wall St. Rank hold XBIT as of Q3 2024.

  • Marshall Wace reported no remaining XBiotech position as of Q3 2024 after selling out during the quarter.
  • Marshall Wace sold 10,573 XBiotech shares in Q3 2024, an estimated $54.3K.
  • Marshall Wace first reported a position in XBiotech in Q1 2019 and held it in 5 quarters.
  • Marshall Wace's XBiotech position peaked at $682K in Q1 2019.
  • 50 funds tracked by Wall St. Rank held XBiotech as of Q3 2024.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.